Citadel Advisors’s Sonnet BioTherapeutics SONN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24,013
| Closed | -$35.1K | – | 6854 |
|
|
2024
Q4 | $35.1K | Buy |
+24,013
| New | +$35.1K | ﹤0.01% | 5545 |
|
|
2024
Q1 | – | Sell |
-3,681
| Closed | -$51.2K | – | 6778 |
|
|
2023
Q4 | $51.2K | Buy |
+3,681
| New | +$51.2K | ﹤0.01% | 5108 |
|
|
2022
Q3 | – | Sell |
-6
| Closed | -$4K | – | 6650 |
|
|
2022
Q2 | $4K | Sell |
6
-159
| -96% | -$106K | ﹤0.01% | 5878 |
|
|
2022
Q1 | $153K | Buy |
+165
| New | +$153K | ﹤0.01% | 5450 |
|
|
2021
Q2 | – | Sell |
-46
| Closed | -$255K | – | 7040 |
|
|
2021
Q1 | $255K | Buy |
+46
| New | +$255K | ﹤0.01% | 5183 |
|
|
2020
Q1 | – | Hold |
0
| – | -$14K | – | 5267 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4544 |
|
|
2019
Q2 | – | Sell |
-1
| Closed | -$80K | – | 5069 |
|
|
2019
Q1 | $80K | Buy |
+1
| New | +$80K | ﹤0.01% | 4135 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4207 |
|
|
2017
Q1 | – | Hold |
0
| – | -$17K | – | 4132 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 3476 |
|
|
2016
Q3 | – | Hold |
0
| – | -$15K | – | 4023 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 3266 |
|
|
2015
Q3 | – | Hold |
0
| – | -$90K | – | 4266 |
|
|
2015
Q2 | – | Hold |
0
| – | -$34K | – | 3292 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 3454 |
|